PDCD1 and non-small cell lung carcinoma: Wang et al. [17] examined the correlation between bTMB and TMB in tumor tissue (tTMB) in order to assess the value of bTMB for selecting patients with advanced NSCLC that could benefit from anti-PD-1 and anti-PD-L1 therapies.